Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.879
-0.005 (-0.51%)
At close: Apr 28, 2026, 4:00 PM EDT
0.897
+0.018 (2.05%)
Pre-market: Apr 29, 2026, 8:08 AM EDT
RVPH Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 11 | 33 | 84 | 144 | 87 | 40 | |
| Market Cap Growth | -64.29% | -61.33% | -41.36% | 65.49% | 115.01% | -49.95% | |
| Enterprise Value | -3 | 19 | 79 | 139 | 64 | 7 | |
| Last Close Price | 0.88 | 5.58 | 36.20 | 103.00 | 85.00 | 57.80 | |
| PB Ratio | 0.60 | 3.77 | 103.76 | 25.14 | 10.35 | 1.41 | |
| P/TBV Ratio | 1.30 | 3.77 | 103.76 | 25.14 | 10.35 | 1.41 | |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.56 | - | - | - | |
| Net Debt / Equity Ratio | -1.62 | -1.62 | -16.02 | -4.09 | -2.21 | -1.03 | |
| Net Debt / EBITDA Ratio | - | - | - | - | - | 2.94 | |
| Quick Ratio | 1.99 | 1.99 | 0.92 | 1.36 | 1.86 | 12.66 | |
| Current Ratio | 2.08 | 2.08 | 1.01 | 1.38 | 1.90 | 13.39 | |
| Return on Equity (ROE) | -419.97% | -419.97% | -916.17% | -556.38% | -152.43% | -49.91% | |
| Return on Assets (ROA) | -80.35% | -80.35% | -98.20% | -115.85% | -70.11% | -31.45% | |
| Return on Capital Employed (ROCE) | -233.60% | -233.60% | -3416.10% | -605.40% | -315.00% | -34.80% | |
| Earnings Yield | -176.42% | -60.93% | -35.49% | -27.31% | -32.53% | -21.09% | |
| Buyback Yield / Dilution | -114.96% | -114.96% | -41.84% | -21.94% | -31.95% | -383.10% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.